Astal Laboratories Ltd - 512600 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Astal Laboratories announced the appointment of M/s. Khedar Ankur & Associates as the new statutory auditors for its material wholly owned subsidiary, Sriven Pharmachem India Private Limited, effective May 19, 2026. This appointment fills a casual vacancy created by the resignation of the previous auditors.
May 20 2026 14:05:00
Astal Laboratories Ltd - 512600 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Astal Laboratories received a monitoring agency report confirming no deviation in the utilization of INR 276.87 crore funds from its preferential issue, aimed at acquiring Sriven Pharmachem India Limited to expand its product portfolio.
May 15 2026 17:05:00
Astal Laboratories Ltd - 512600 - Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors
Astal Laboratories' material subsidiary, Sriven Pharmachem India Private Limited, announced the resignation of its statutory auditors, M/s. Balaji V & Co. The auditors resigned mid-term, effective May 13, 2026, as they do not possess a mandatory Peer Review Certificate required for auditing material subsidiaries, preventing them from completing the audit for the quarter and financial year ended March 31, 2026.
May 14 2026 12:05:00
Astal Laboratories Ltd - 512600 - Announcement under Regulation 30 (LODR)-Allotment
Astal Laboratories allotted 14.7 lakh equity shares at Rs. 40 each, upon conversion of warrants held by non-promoter investors. This issuance increases the company's paid-up capital by 3.48%.
May 12 2026 18:05:00
Astal Laboratories Ltd - 512600 - Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th May, 2026.
Astal Laboratories allotted 1.47 million equity shares at Rs. 40 per share, totaling Rs. 4.41 crore, through the conversion of warrants. These shares were issued to 11 non-promoter investors.
May 12 2026 17:05:00
Read More